Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer

European Urology

Volumn 55, Issue 1, 2009, Pages 227-236

  Pinkawa, Michael ^a   Gagel, Bernd ^a   Piroth, Marc D ^a   Fischedick, Karin ^a   Asadpour, Branka ^a   Kehl, Mareike ^a   Klotz, Jens ^a   Eble, Michael J ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Erectile dysfunction; Prostate cancer; Quality of life; Three dimensional conformal radiotherapy

Indexed keywords

PHOSPHODIESTERASE V INHIBITOR; PROSTATE SPECIFIC ANTIGEN; SILDENAFIL; TADALAFIL; VARDENAFIL;

ADULT; AGED; AGING; ARTICLE; CANCER RADIOTHERAPY; COMPUTER ASSISTED RADIOTHERAPY; DIABETES MELLITUS; ERECTILE DYSFUNCTION; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PENIS ERECTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; QUESTIONNAIRE; RADIATION DOSE; RISK FACTOR; SCORING SYSTEM; SEXUAL FUNCTION; SEXUAL INTERCOURSE; STROKE; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ERECTILE DYSFUNCTION; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; RADIOTHERAPY;

EID: 56249102127     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2008.03.026     Document Type: Article

References (26)

1. Green H.J., Pakenham K.I., Headley B.C., et al. Quality of life compared during pharmacological treatments and clinical monitoring for non-localized prostate cancer: a randomized controlled trial. BJU Int 93 (2004) 975-979
2. Valicenti R.K., Winter K., Cox J.D., et al. RTOG 94-06: is the addition of neoadjuvant hormonal therapy to dose-escalated 3D conformal radiation therapy for prostate cancer associated with treatment toxicity?. Int J Radiat Oncol Biol Phys 57 (2003) 614-620
3. Incrocci L., Slob A.K., Levendag P.C., et al. Sexual (dys)function after radiotherapy for prostate cancer: a review. Int J Radiat Oncol Biol Phys 52 (2002) 681-693
4. Roach III M., Chinn D.M., Holland J., and Clarke M. A pilot study of sexual function and quality of life following 3d conformal radiotherapy for clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 35 (1996) 869-874
5. Wespes E., Amar E., Hatzichristou D., et al. Guidelines on erectile dysfunction. Eur Urol 41 (2002) 1-5
6. Davidson S.E., Burns M.P., Routledge J.A., et al. Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian glossary. Radiother Oncol 69 (2003) 195-200
7. Salonia A., Zanni G., Gallina A., et al. Baseline potency in candidates for bilateral nerve-sparing radical retropubic prostatectomy. Eur Urol 50 (2006) 360-365
8. Moul J.W., Anderson J., Penson D.F., et al. Early prostate cancer: prevention, treatment modalities, and quality of life issues. Eur Urol 44 (2003) 283-293
9. Wei J.T., Dunn R.L., Litwin M.S., Sandler H.M., and Sanda M.G. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology 56 (2000) 899-905
10. Pinkawa M., Gagel B., Piroth M.D., et al. Changes of dose delivery distribution within the first month after permanent interstitial brachytherapy for prostate cancer. Strahlenther Onkol 182 (2006) 525-530
11. International Commission on Radiation Units and Measurements. ICRU Report 50: Prescribing, recording and reporting photon beam therapy. Bethesda, Maryland. International Commission on Radiation Units and Measurements 1993.
12. van der Wielen G.J., van Putten W.L., Incrocci L., et al. Sexual function after three-dimensional conformal radiotherapy for prostate cancer: results from a dose-escalation trial. Int J Radiat Oncol Biol Phys 68 (2007) 479-484
13. Turner S.L., Adams K., Bull C.A., et al. Sexual dysfunction after radical radiation therapy for prostate cancer: a prospective evaluation. Urology 54 (1999) 124-129
14. Roach M., Winter K., Michaelski J., et al. Penile bulb dose and impotence after three-dimensional conformal radiotherapy for prostate cancer on RTOG 9406: findings from a prospective, multi-institutional, phase I/II dose-escalation study. Int J Radiat Oncol Biol Phys 60 (2004) 1351-1356
15. Wespes E., Amar E., Hatzichristou D., et al. EAU Guidelines on erectile dysfunction: an update. Eur Urol 49 (2006) 806-815
16. Lue T.F. Erectile dysfunction. N Engl J Med 342 (2000) 1802-1813
17. Hoesl C.E., Woll E.M., Burkart M., and Altwein J.E. Erectile dysfunction (ED) is prevalent, bothersome and underdiagnosed in patients consulting urologists for benign prostatic syndrome (BPS). Eur Urol 47 (2005) 511-517
18. Pinkawa M., Fischedick K., Asadpour B., et al. Toxicity profile with a large prostate volume after external beam radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70 (2008) 83-89
19. Antunes A.A., Srougi M., Dall'Oglio M.F., et al. The role of BPH, lower urinary tract symptoms and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening. J Sex Med 5 (2008) 1702-1707
20. Dubbelman Y.D., Dohle G.R., Schröder F.H., et al. Sexual function before and after radical retropubic prostatectomy: A systematic review of prognostic indicators for a successful outcome. Eur Urol 50 (2006) 711-720
21. Incrocci L., Slagter C., Slob A.K., et al. A randomized, double-blind, placebo-controlled, cross-over study to assess the efficacy of tadalafil (Cialis) in the treatment of erectile dysfunction following three-dimensional conformal external-beam radiotherapy for prostatic carcinoma. Int J Radiat Oncol Biol Phys 66 (2006) 439-444
22. Zelefsky M.J., McKee A.B., Lee H., and Leibel S.A. Efficacy of oral sildenafil in patients with erectile dysfunction after radiotherapy for carcinoma of the prostate. Urology 53 (1999) 775-778
23. Valicenti R.K., Choi E., Chen C., et al. Sildenafil citrate effectively reverses sexual dysfunction induced by three-dimensional conformal radiation therapy. Urology 57 (2001) 769-773
24. Incrocci L., Hop W.C.J., and Slob A.K. Efficacy of sildenafil in an open-label study as a continuation of a double-blind study in the treatment of erectile dysfunction after radiotherapy for prostate cancer. Urology 62 (2003) 116-120
25. Montorsi F., Briganti A., Salonia A., et al. Can phosphodiesterase type 5 inhibitors cure erectile dysfunction?. Eur Urol 49 (2006) 979-986
26. Zelefsky M.J., and Eid J.F. Elucidating the etiology of erectile dysfunction after definitive therapy for prostatic cancer. Int J Radiat Oncol Biol Phys 40 (1998) 129-133